Directory Inc.

About

Pfizer Inc. (NYSE: PFE, /?fa?z?r/)[2] is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange[3]. It is one of the world’s largest pharmaceutical companies.[4] It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004.[5] Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.[6] On December 19, 2018, Pfizer announced a joint merger of their consumer healthcare division with UK pharma giant GlaxoSmithKline; the British company will maintain a controlling share (listed at 68%).[7] The company develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology. Its products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin) for neuropathic pain and fibromyalgia; Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil) for erectile dysfunction; and Celebrex (also Celebra, celecoxib), an anti-inflammatory drug. In 2016, Pfizer Inc. was expected to merge with Allergan, Plc to create the Ireland-based “Pfizer plc” in a deal that would have been worth $160 billion.[8] The merger was called off in April 2016, however, because of new rules from the United States Treasury against tax inversions, a method of avoiding taxes by merging with a foreign company.[9] The company has made the second-largest pharmaceutical settlement with the United States Department of Justice.